|
|
|
Volumn 15, Issue 1, 2007, Pages 128-135
|
|
Researching safety and cost-effectiveness in the life cycle of nanomedicine.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTICLE;
AUSTRALIA;
BIOTECHNOLOGY;
COST BENEFIT ANALYSIS;
ECONOMICS;
GOVERNMENT REGULATION;
HEALTH SERVICES RESEARCH;
HUMAN;
LEGAL ASPECT;
NANOMEDICINE;
PUBLIC HEALTH;
RISK ASSESSMENT;
SAFETY;
UNITED KINGDOM;
AUSTRALIA;
BIOTECHNOLOGY;
COST-BENEFIT ANALYSIS;
GOVERNMENT REGULATION;
GREAT BRITAIN;
HEALTH SERVICES RESEARCH;
HUMANS;
NANOMEDICINE;
PUBLIC HEALTH;
RISK ASSESSMENT;
SAFETY;
|
|
EID: 35848960125
PISSN: 1320159X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (11)
|
|
References (0)
|
